Cargando…

Use of Bortezomib in the Treatment of C3 Glomerulonephritis Refractory to Eculizumab and Rituximab

Detalles Bibliográficos
Autores principales: Hui, Jessica W., Banks, Mindy, Nadasdy, Tibor, Rovin, Brad H., Abbott, Jordan K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7270979/
https://www.ncbi.nlm.nih.gov/pubmed/32518880
http://dx.doi.org/10.1016/j.ekir.2020.03.022
_version_ 1783542000718446592
author Hui, Jessica W.
Banks, Mindy
Nadasdy, Tibor
Rovin, Brad H.
Abbott, Jordan K.
author_facet Hui, Jessica W.
Banks, Mindy
Nadasdy, Tibor
Rovin, Brad H.
Abbott, Jordan K.
author_sort Hui, Jessica W.
collection PubMed
description
format Online
Article
Text
id pubmed-7270979
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-72709792020-06-08 Use of Bortezomib in the Treatment of C3 Glomerulonephritis Refractory to Eculizumab and Rituximab Hui, Jessica W. Banks, Mindy Nadasdy, Tibor Rovin, Brad H. Abbott, Jordan K. Kidney Int Rep Nephrology Round Elsevier 2020-03-30 /pmc/articles/PMC7270979/ /pubmed/32518880 http://dx.doi.org/10.1016/j.ekir.2020.03.022 Text en © 2020 International Society of Nephrology. Published by Elsevier Inc. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Nephrology Round
Hui, Jessica W.
Banks, Mindy
Nadasdy, Tibor
Rovin, Brad H.
Abbott, Jordan K.
Use of Bortezomib in the Treatment of C3 Glomerulonephritis Refractory to Eculizumab and Rituximab
title Use of Bortezomib in the Treatment of C3 Glomerulonephritis Refractory to Eculizumab and Rituximab
title_full Use of Bortezomib in the Treatment of C3 Glomerulonephritis Refractory to Eculizumab and Rituximab
title_fullStr Use of Bortezomib in the Treatment of C3 Glomerulonephritis Refractory to Eculizumab and Rituximab
title_full_unstemmed Use of Bortezomib in the Treatment of C3 Glomerulonephritis Refractory to Eculizumab and Rituximab
title_short Use of Bortezomib in the Treatment of C3 Glomerulonephritis Refractory to Eculizumab and Rituximab
title_sort use of bortezomib in the treatment of c3 glomerulonephritis refractory to eculizumab and rituximab
topic Nephrology Round
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7270979/
https://www.ncbi.nlm.nih.gov/pubmed/32518880
http://dx.doi.org/10.1016/j.ekir.2020.03.022
work_keys_str_mv AT huijessicaw useofbortezomibinthetreatmentofc3glomerulonephritisrefractorytoeculizumabandrituximab
AT banksmindy useofbortezomibinthetreatmentofc3glomerulonephritisrefractorytoeculizumabandrituximab
AT nadasdytibor useofbortezomibinthetreatmentofc3glomerulonephritisrefractorytoeculizumabandrituximab
AT rovinbradh useofbortezomibinthetreatmentofc3glomerulonephritisrefractorytoeculizumabandrituximab
AT abbottjordank useofbortezomibinthetreatmentofc3glomerulonephritisrefractorytoeculizumabandrituximab